Positive Inotropic Effect of Levosimendan is Correlated to its Stereoselective Ca2+‐Sensitizing Effect but not to Stereoselective Phosphodiesterase Inhibition
- 24 January 2006
- journal article
- research article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 98 (1) , 74-78
- https://doi.org/10.1111/j.1742-7843.2006.pto_231.x
Abstract
In order to clarify the mechanisms of the positive inotropic actions of levosimendan and its optical isomer, dextrosimendan, we compared their concentration‐dependent effects in intact papillary muscles, permeabilized cardiomyocytes and in purified phosphodiesterase enzyme preparations of guinea‐pig hearts. In papillary muscles twitch tension increased with EC50values of 60 nM and 2.8 μM for levosimendan and dextrosimendan, respectively. Hence, the two enantiomers exhibited a 47 times potency difference in their positive inotropic effects in a preparation where theoretically Ca2+‐sensitization and phosphodiesterase inhibition could both contribute to the positive inotropic effects. In guinea‐pig cardiomyocytes, levosimendan and dextrosimendan increased isometric force production (at pCa 6.2) due to Ca2+‐sensitization with EC50values of 8.4 nM and 0.64 μM, respectively, with a similar relative potency difference of 76. A major difference appeared in their relative pharmacological potencies, however, when the inhibitory effects of the two enantiomers were assayed on phosphodiesterase III, purified from guinea pig left ventricle (i.e. the phosphodiesterase isoenzyme which is dominant in that tissue). Levosimendan was a 427 times more potent phosphodiesterase inhibitor than dextrosimendan, with IC50values of 7.5 nM, and 3.2 μM, respectively. Taken together, our data support the hypothesis that levosimendan and dextrosimendan exert their positive inotropic effects via a stereoselective Ca2+‐sensitizing mechanism and not via stereoselective inhibition of phosphodiesterase III in the myocardium.Keywords
This publication has 20 references indexed in Scilit:
- The effects of levosimendan and OR-1896 on isolated hearts, myocyte-sized preparations and phosphodiesterase enzymes of the guinea pigEuropean Journal of Pharmacology, 2004
- Stereoselective binding of levosimendan to cardiac troponin C causes Ca2+-sensitizationEuropean Journal of Pharmacology, 2004
- The mechanism of the force enhancement by mgADP under simulated isChaemic conditions in rat cardiac myocytesThe Journal of Physiology, 2002
- Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trialThe Lancet, 2002
- Binding of Levosimendan, a Calcium Sensitizer, to Cardiac Troponin CJournal of Biological Chemistry, 2001
- Further Evidence for the Cardiac Troponin C Mediated Calcium Sensitization by Levosimendan: Structure-response and Binding Analysis with Analogs of LevosimendanJournal of Molecular and Cellular Cardiology, 2000
- Troponin C-mediated calcium sensitization by levosimendan accelarates the proportional development of isometric tensionJournal of Molecular and Cellular Cardiology, 1995
- Troponin C–Mediated Calcium Sensitization Induced by Levosimendan Does Not Impair RelaxationJournal of Cardiovascular Pharmacology, 1995
- The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle. Implications for the mechanism of action of selective phosphodiesterase inhibitorsBiochemical Journal, 1987